HUMAIN Award Recipient | Kristin Schüler
InSphero
HUMAIN Award Recipient | Kristin Schüler
3:08
Assay-Ready 3D InSight™ Microtissues: Human Relevant Data from Day One
InSphero
Assay-Ready 3D InSight™ Microtissues: Human Relevant Data from Day One
0:51
Gri3D automation
InSphero
Gri3D automation
0:29
Akura™ Organ-on-Chip Technology – Insights from Our Team!
InSphero
Akura™ Organ-on-Chip Technology – Insights from Our Team!
1:49
250 Donors. 400+ Islet Microtissue Productions. Thousands of Experiments. One Powerful Platform.
InSphero
250 Donors. 400+ Islet Microtissue Productions. Thousands of Experiments. One Powerful Platform.
2:30
Automatic Processing of ARCTis™ - Always Ready Cryo Tissues with CyBio Felix
InSphero
Automatic Processing of ARCTis™ - Always Ready Cryo Tissues with CyBio Felix
2:14
ARCTis™ – Insights from Our Team!
InSphero
ARCTis™ – Insights from Our Team!
1:21
InSphero Reflections and Forecasts 2024/2025 | Madhu Nag, Jan Lichtenberg and Rizwan Chaudhrey
InSphero
InSphero Reflections and Forecasts 2024/2025 | Madhu Nag, Jan Lichtenberg and Rizwan Chaudhrey
41:08
Akura™ Plates – Insights from Our Team!
InSphero
Akura™ Plates – Insights from Our Team!
1:35
InSphero at SLAS 2025 | Meet Our Technological Partners
InSphero
InSphero at SLAS 2025 | Meet Our Technological Partners
5:27
InSphero at SLAS 2025 introducing the ARCTis - Always Ready Cryo Tissue
InSphero
InSphero at SLAS 2025 introducing the ARCTis - Always Ready Cryo Tissue
7:59
InSphero at SLAS 2025 | Spotlight Session | Akura™ Microplates: The Backbone of 3D Cell Culture
InSphero
InSphero at SLAS 2025 | Spotlight Session | Akura™ Microplates: The Backbone of 3D Cell Culture
20:39
The MASH CALL Initiative - Explained by Dr. Francisco Verdeguer
InSphero
The MASH CALL Initiative - Explained by Dr. Francisco Verdeguer
1:42
Building on Success: InSphero Expands Its Presence on the SLAS Board of Directors
InSphero
Building on Success: InSphero Expands Its Presence on the SLAS Board of Directors
6:12
How does ARCTis™ overcome the limits of current in vitro oncology models?
InSphero
How does ARCTis™ overcome the limits of current in vitro oncology models?
3:42
Why ARCTis™ Cryo Solution? InSphero’s Answer to Oncology Research Needs
InSphero
Why ARCTis™ Cryo Solution? InSphero’s Answer to Oncology Research Needs
1:55
Akura™ Immune Flow Organ-on-Chip Platform Explainer Video
InSphero
Akura™ Immune Flow Organ-on-Chip Platform Explainer Video
0:32
InSphero and FDA's NCTR Publish the Largest Benchmark Research on Liver Toxicity
InSphero
InSphero and FDA's NCTR Publish the Largest Benchmark Research on Liver Toxicity
2:53
InSphero’s Mission to Reduce Animal Testing in Drug Discovery - an Interview with LSCV
InSphero
InSphero’s Mission to Reduce Animal Testing in Drug Discovery - an Interview with LSCV
10:50
Manual medium exchange under 2 minutes with InSphero Akura™ 96 Spheroid Microplate
InSphero
Manual medium exchange under 2 minutes with InSphero Akura™ 96 Spheroid Microplate
0:56
Introducing InSphero
InSphero
Introducing InSphero
1:37
Akura™ 96 Spheroid Microplate | All-in-one plates for spheroids and organoids
InSphero
Akura™ 96 Spheroid Microplate | All-in-one plates for spheroids and organoids
0:51
Human 3D in vitro NASH model for efficacy testing of clinical drug candidates | InSphero
InSphero
Human 3D in vitro NASH model for efficacy testing of clinical drug candidates | InSphero
2:10
How to Evaluate Preclinical and Clinical DILI
InSphero
How to Evaluate Preclinical and Clinical DILI
51:44
Artificial Intelligence in Digital Pathology: Quantification of Fibrosis in Human 3D NASH Model
InSphero
Artificial Intelligence in Digital Pathology: Quantification of Fibrosis in Human 3D NASH Model
48:24
Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes | Joan Mir Coll
InSphero
Human Islet Microtissues as an In Vitro and an In Vivo Model System for Diabetes | Joan Mir Coll
1:15
InSphero and Hamilton Collaborate to Improve the Production and Handling of Spheroids
InSphero
InSphero and Hamilton Collaborate to Improve the Production and Handling of Spheroids
0:47
Implementing High Resolution High Content Image Analysis in 3D Spheroid Models | InSphero Webinars
InSphero
Implementing High Resolution High Content Image Analysis in 3D Spheroid Models | InSphero Webinars
38:14
Microfluidic Perifusion Platform for Studying Insulin Release Dynamics | InSphero Webinars
InSphero
Microfluidic Perifusion Platform for Studying Insulin Release Dynamics | InSphero Webinars
39:33
Predicting Metabolism Related Drug-Drug Interactions with Organ on a Chip | InSphero Webinars
InSphero
Predicting Metabolism Related Drug-Drug Interactions with Organ on a Chip | InSphero Webinars
35:39
Optimizing 3D Spheroid Models for Efficient DILI Screening | InSphero Webinars
InSphero
Optimizing 3D Spheroid Models for Efficient DILI Screening | InSphero Webinars
34:04
A Novel Causality Framework for Teasing Out DILI Mechanisms | InSphero Webinars
InSphero
A Novel Causality Framework for Teasing Out DILI Mechanisms | InSphero Webinars
31:33
InSide InSphero with Armin on alternatives to animal testing
InSphero
InSide InSphero with Armin on alternatives to animal testing
2:25
High Content Imaging of 3D In Vitro Cell Culture with InSphero & Yokogawa
InSphero
High Content Imaging of 3D In Vitro Cell Culture with InSphero & Yokogawa
1:34
Redefining NASH drug discovery: a new approach to complex disease modeling | InSphero Webinars
InSphero
Redefining NASH drug discovery: a new approach to complex disease modeling | InSphero Webinars
26:40
Multi-tissue organ networks in vitro | Akura™ Flow
InSphero
Multi-tissue organ networks in vitro | Akura™ Flow
0:22
Unpacking InSphero 3D InSight™ Assay-Ready Microtissues
InSphero
Unpacking InSphero 3D InSight™ Assay-Ready Microtissues
1:32
Picking Islets for diabetes research
InSphero
Picking Islets for diabetes research
1:35
In vitro human liver models of NAFLD and NASH | 3D InSight™ InSphero
InSphero
In vitro human liver models of NAFLD and NASH | 3D InSight™ InSphero
3:47
Organ-on-a-chip technology and microphysiological system | Akura™ Flow
InSphero
Organ-on-a-chip technology and microphysiological system | Akura™ Flow
2:22
InSphero CEO Jan Lichtenberg Receives EY Entrepreneur of the Year Emerging Entrepreneur Award
InSphero
InSphero CEO Jan Lichtenberg Receives EY Entrepreneur of the Year Emerging Entrepreneur Award
2:21
Transforming Drug Discovery with InSphero
InSphero
Transforming Drug Discovery with InSphero
3:47
InSide InSphero with Frank on collaborations and partnerships with pharma
InSphero
InSide InSphero with Frank on collaborations and partnerships with pharma
2:50
InSphero Akura™ Flow Organ-on-a- chip Technology
InSphero
InSphero Akura™ Flow Organ-on-a- chip Technology
4:33
Transforming Islet Research – 3D InSight™ Islet Microtissues - ADA2017
InSphero
Transforming Islet Research – 3D InSight™ Islet Microtissues - ADA2017
1:54
InSphero 384 Microtissue Format
InSphero
InSphero 384 Microtissue Format
1:19
InSphero introduces 384-well platform at SLAS2017
InSphero
InSphero introduces 384-well platform at SLAS2017
1:25
3D InSight™ Cardiac Microtissues
InSphero
3D InSight™ Cardiac Microtissues
0:15
3D InSight™ Human Liver Microtissue
InSphero
3D InSight™ Human Liver Microtissue
0:48
InSphero CEO Jan Lichtenberg Receives EY Entrepreneur of the Year "Emerging Entrepreneur" Award
InSphero
InSphero CEO Jan Lichtenberg Receives EY Entrepreneur of the Year "Emerging Entrepreneur" Award
2:21
Rapidly image 3D cell culture: Introducing the Cell3Imager
InSphero
Rapidly image 3D cell culture: Introducing the Cell3Imager
2:23
3D InSight™ Tumor Microtissues InSphero
InSphero
3D InSight™ Tumor Microtissues InSphero
2:07
3D Human Liver Microtissues for in-vitro toxicology - A brief introduction
InSphero
3D Human Liver Microtissues for in-vitro toxicology - A brief introduction
1:52
Beating 3D heart-muscle microtissues
InSphero
Beating 3D heart-muscle microtissues
0:35
3D spheroid formation in InSphero GravityPLUS system
InSphero
3D spheroid formation in InSphero GravityPLUS system
0:25
InSphero 3D Microtissues for Cell-Based Assays
InSphero
InSphero 3D Microtissues for Cell-Based Assays
1:47